Contrasting NantHealth (NH) and Cotiviti Holdings (COTV)
NantHealth (NYSE: NH) and Cotiviti Holdings (NASDAQ:COTV) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.
This table compares NantHealth and Cotiviti Holdings’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of recent ratings and price targets for NantHealth and Cotiviti Holdings, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
NantHealth presently has a consensus price target of $9.25, suggesting a potential upside of 218.97%. Cotiviti Holdings has a consensus price target of $41.20, suggesting a potential upside of 17.58%. Given NantHealth’s stronger consensus rating and higher possible upside, equities research analysts clearly believe NantHealth is more favorable than Cotiviti Holdings.
Earnings & Valuation
This table compares NantHealth and Cotiviti Holdings’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|NantHealth||$98.18 million||3.60||-$116.13 million||N/A||N/A|
|Cotiviti Holdings||$651.90 million||4.95||$222.12 million||N/A||N/A|
Cotiviti Holdings has higher revenue and earnings than NantHealth.
Cotiviti Holdings beats NantHealth on 7 of the 9 factors compared between the two stocks.
NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.
About Cotiviti Holdings
Cotiviti Holdings, Inc. is a provider of analytics-driven payment accuracy solutions. The Company focuses primarily on the healthcare sector. The Company operates through two segments: Healthcare, and Global Retail and Other. Through its Healthcare segment, the Company offers prospective and retrospective claims accuracy solutions to healthcare payers in the United States. The Company also provides analytics-based solutions unrelated to its healthcare payment accuracy solutions in the United States. Through its Global Retail and Other segment, the Company provides retrospective claims accuracy solutions to retailers primarily in the United States, Canada and the United Kingdom, as well as solutions that manage payment networks for a range of clients. The Company leverages its technology platform, configurable analytics, information assets and expertise in healthcare reimbursement to help its clients develop their claims payment accuracy.
Receive News & Ratings for NantHealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.